Alzheimers

POSTED ON MARCH 19, 2024BY CHRIS YOUNG It’s estimated over 580 thousand Floridians are living with Alzheimer’s disease. A study could lead to a simpler way to detect the disease. The study, called Bio-Hermes, showed how new Alzheimer’s detecting blood tests perform across a broad range of races and ethnicities for the first time. Currently, scans or spinal taps […]

By Editor,  MAR 16, 2024 WASHINGTON, DC (Feb. 19, 2024) — Today, the Global Alzheimer’s Platform Foundation (GAP) recognized Orange County resident Jeannie Weiss for her exceptional role in Alzheimer’s research. Jeannie Weiss received GAP’s 2023 National Citizen Scientist Champion Award®, which is given to individuals who act as a stimulus in bringing new, novel approaches to Alzheimer’s research […]

08 Mar 2024 ANALYSIS by Cathy Kelly; catherine.kelly@citeline.comExecutive Summary Donanemab’s review delay will create more distance from Lilly’s direct-to-consumer advertising spotlighting its commitment to Alzheimer’s research. The company has also been supporting development of blood-based tools for early diagnoses, though they would not eliminate PET scans. Eli Lilly and Company launched unbranded direct-to-consumer TV advertising […]

Washington D.C., Mar. 08, 2024- The U.S. Food and Drug Administration (FDA) announced today that it expects to convene a meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) to discuss the Phase 3 TRAILBLAZER-ALZ 2 trial, which evaluated the efficacy and safety of Donanemab in early symptomatic Alzheimer’s disease. As the […]

By Katharine Lang on March 4, 2024 — Fact checked by Amanda WardA simple blood test, may in the future, help diagnose Alzheimer’s early. Image credit: Oleksii Syrotkin/Stocksy. Dementia currently affects around 60 millionTrusted Source people worldwide, and the number is projected to rise to more than 150 million by 2050. Alzheimer’s disease, the most common form of dementia, causes 60-80% of cases. Available treatments […]

Oral Presentation on Bio-Hermes to Take Place at Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (ADPD) Washington D.C., Mar 04, 2024- Global Alzheimer’s Platform Foundation®, (GAP) is pleased to share that new data from the ground-breaking blood-based and digital biomarker platform study, Bio-Hermes, will be shared by Douglas Beauregard, Project Director of Clinical Operations […]

By  Community News Releases  -March 2, 2024 The Global Alzheimer’s Platform Foundation (GAP) recently recognized Miami resident Joanne Bridges with the 2023 National Citizen Scientist Collaborator Award. Bridges was selected from a pool of nominees from across North America to receive elevated recognition and be honored for supporting a clinical trial volunteer by serving as […]

LabPulse.com staff writers Mar 1, 2024The first results from the Bio-Hermes study have been released, showing a strong correlation between several blood-based and digital biomarkers with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer’s disease (AD). The findings from the study, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, show […]

By LabMedica International staff writersPosted on 29 Feb 2024      Alzheimer’s disease, which traditionally requires costly scans or invasive spinal taps for diagnosis, is now closer to being more easily identified through innovative blood tests. This advancement is particularly crucial with the recent approval of disease-modifying treatments for Alzheimer’s. Now, the results of a study […]

Feb 28, 2024 | Jessica Kim Cohen NEW YORK – Results from blood-based biomarker tests correlated with the presence of beta-amyloid detected using established Alzheimer’s disease diagnostics, according to a study published Wednesday. PET scans and cerebrospinal fluid (CSF) analyses are highly accurate and established methods of identifying elevated levels of beta-amyloid, a hallmark of Alzheimer’s. However, these […]

The results of the Bio-Hermes study appear in Alzheimer’s & Dementia showing how new Alzheimer’s detecting blood tests perform across a broad range of races and ethnicities for the first time. Washington D.C., Feb. 28, 2024- The Global Alzheimer’s Platform Foundation®, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over […]

By Hope Dean, Published: Feb. 21, 2024 at 3:31 PM EST ATLANTA, Ga. (Atlanta News First) – A veteran from Ellenwood is being recognized by a nonprofit foundation for helping advance research on Alzheimer’s disease. Rod Barber won the National Citizen Scientist Catalyst Award, the Global Alzheimer’s Platform Foundation announced on Monday. He has volunteered at CenExel iResearch in […]

Feb. 5 On Thursday, February 1, El Faro Health and Therapeutics played host to a heartfelt Citizen Scientist Award ceremony, honoring Mr. Martin Carrion for his exemplary dedication and advocacy in the realm of Alzheimer’s research. Mr. Carrion’s contributions have not only been commendable but have also left an indelible impact. The ceremony served as […]

The Global Alzheimer’s Platform Foundation’s® (GAP) 2023 Citizen Scientist Award© recipients include a philanthropic Mustang enthusiast, an “old-school” Veteran, an innovative volunteer with Parkinson’s disease and an Alzheimer’s advocate/ inspirational study partner. WASHINGTON, DC (Feb. 19, 2024) — Today, the Global Alzheimer’s Platform Foundation (GAP) proudly announced the 2023 National Citizen Scientist Awards® elevated honorees.  […]

Sarasota Researchers Hold FREE Bilingual Memory Screening for Community on Saturday, February 3 Intercoastal Medical Group Neurology & Research Clinic of Sarasota is hosting a FREE memory screening for individuals 50+ to raise awareness for Alzheimer’s Disease Intercoastal Medical Group Neurology and Research Clinic will hold a free memory screening event on Saturday, February 3, […]

The medications have not been widely tested in Black people with the disease,underscoring stark — and persistent — disparities By Laurie McGinley, January 29, 2024 at 6:00 a.m. EST ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford settles into a quiet corner of abustling neurology clinic, an IV line delivering a colorless liquid […]

By Evyn Moon, PublishedJanuary 23, 2024 9:42AM, Health, FOX 13 News TAMPA, Fla. – A blood test could soon be used to identify a type of protein that is linked to Alzheimer’s disease before symptoms arise with 97% accuracy, a new study shows.  The study involves testing blood for biomarkers that could build up in the brain. The testing could […]

We thank J&J for their leadership as they announced new efforts to combat Alzheimer’s disease, specifically their vaccine trial. In taking on this tau antibody and a tau-targeting vaccine, J&J is bringing hope to those impacted by Alzheimer’s disease, and addressing the need for cutting-edge research by launching this exciting trial. We are grateful for […]

Atlanta News First- By Sawyer Buccy Published: Nov. 29, 2023 at 4:51 PM EST|Updated: 15 hours ago ATLANTA, Ga. (Atlanta News First) – You probably know someone whose life has been impacted in one way or another by Alzheimer’s. Some people are fighting to find ways to slow the progression of the disease through clinical trials. One Georgia […]

By JOANN GREER November 18, 2023 at 5:30 a.m. My husband and I know first-hand the toll that Alzheimer’s Disease has as we have cared for a mom and stepfather who lived with Alzheimer’s Disease before they passed away. With it being National Alzheimer’s Disease Awareness Month and National Family Caregiver’s Month, we would like to […]

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida take Alzheimer’s Disease clinical research on the road By Staff | Oct 4, 2023 Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida will be driving clinical research into the community as they introduce the Memory Machine to Fort Myers. The new Memory Machine will allow […]

A new seven-figure ad campaign takes aim – again – at Medicare’s pending coverage decision on Alzheimer’s disease anti-amyloid drugs. UsAgainstAlzheimer’s launched the $1 million-plus national effort Sunday, including a TV ad that ran across the the day’s morning talk news shows. The group is the latest to push back on the Centers for Medicare […]

At a pivotal time in Alzheimer’s research, the GAP Foundation and the Alzheimer’s Drug Discovery Foundation will connect funders with leading innovators Updated on March 26, 2020: The Global Alzheimer’s Platform Foundation (GAP) has announced it is postponing the GAP Innovation Summit that was to be held on May 5, 2020 with our partner, the […]

For the first time in 15 years, there are new Alzheimer’s drug treatments on the horizon that are expected to seek regulatory approval by the FDA and leading experts are increasely optimistic that a major breakthrough in Alzheimer’s research will occur within the next five years. We are at a moment of peak opportunity – […]